The Nevada Drug Transparency Report 2025 presents a comprehensive analysis of pharmaceutical pricing trends, practices, and patterns across the state’s healthcare system. Mandated by Nevada Revised Statutes (NRS) 439B.650, this report compiles and analyzes data from calendar year 2024 to provide stakeholders with critical insights into the pharmaceutical supply chain.